Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

Association of NSAID Use With Risk of Bleeding and Cardiovascular Events in Patients Receiving Antithrombotic Therapy After Myocardial Infarction

(2015) Anne-Marie Schjerning Olsen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Meta-Analysis of Nonsteroidal Anti-Inflammatory Drug Use and Risk of Atrial Fibrillation

(2014) Gang Liu et al.   AMERICAN JOURNAL OF CARDIOLOGY

Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy

(2014) Morten Lamberts et al.   ANNALS OF INTERNAL MEDICINE

Mistaken inference caused by reliance on and misinterpretation of a significance test

(2014) Morten Schmidt et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Wytyczne ESC/ESA dotyczące operacji niekardiochirurgicznych — ocena ryzyka sercowo-naczyniowego i postępowanie w 2014 roku

(2014) Steen Dalby Kristensen et al.   Kardiologia Polska

Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: a population-based follow-up study

(2014) Bouwe P Krijthe et al.   BMJ Open

Bleeding Risk of Patients With Acute Venous Thromboembolism Taking Nonsteroidal Anti-Inflammatory Drugs or Aspirin

(2014) Bruce L. Davidson et al.   JAMA Internal Medicine

Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999–2012

(2014) Morten Schmidt et al.   Clinical Epidemiology

Individual NSAIDs and Upper Gastrointestinal Complications

(2013) Jordi Castellsague et al.   DRUG SAFETY

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy

(2013) Stefan Agewall et al.   EUROPEAN HEART JOURNAL

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

(2013)   LANCET

Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries

(2013) Patricia McGettigan et al.   PLOS MEDICINE

Long-Term Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drug Use According to Time Passed After First-Time Myocardial Infarction

(2012) Anne-Marie Schjerning Olsen et al.   CIRCULATION

Effects of Celecoxib On Restenosis after Coronary Intervention and Evolution of Atherosclerosis (Mini-COREA) Trial: celecoxib, a double-edged sword for patients with angina

(2012) Hyun-Jae Kang et al.   EUROPEAN HEART JOURNAL

The association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: A nationwide case–control study

(2012) Tze-Fan Chao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Association of Perioperative Use of Nonsteroidal Anti-Inflammatory Drugs With Postoperative Myocardial Infarction After Total Joint Replacement

(2012) Spencer S. Liu et al.   REGIONAL ANESTHESIA AND PAIN MEDICINE

Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction

(2011) Anne-Marie Schjerning Olsen et al.   CIRCULATION

Aspirin

(2011) Valentin Fuster et al.   CIRCULATION

Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib

(2011) M. Back et al.   EUROPEAN HEART JOURNAL

Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

(2011) Patricia McGettigan et al.   PLOS MEDICINE

Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga

(2010) Tilo Grosser et al.   Annual Review of Medicine

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

(2010) Morten L. Hansen et al.   ARCHIVES OF INTERNAL MEDICINE

Long-Term Outcome of Adjunctive Celecoxib Treatment After Paclitaxel-Eluting Stent Implantation for the Complex Coronary Lesions

(2010) Jin-Wook Chung et al.   Circulation-Cardiovascular Interventions

Guidelines for Prevention of NSAID-Related Ulcer Complications

(2009) Frank L Lanza et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure

(2009) Gunnar H. Gislason et al.   ARCHIVES OF INTERNAL MEDICINE

Perioperative Myocardial Infarction

(2009) Giora Landesberg et al.   CIRCULATION

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

(2009) Rikke Sørensen et al.   LANCET

Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function

(2009) D. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cardiovascular Safety of the Cyclooxygenase-2 Selective Inhibitors Parecoxib and Valdecoxib in the Postoperative Setting: An Analysis of Integrated Data

(2008) Stephan A. Schug et al.   ANESTHESIA AND ANALGESIA

Risk of Myocardial Infarction and Death Associated With the Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Among Healthy Individuals: A Nationwide Cohort Study

(2008) EL Fosbøl et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials

(2008) Paul A Scott et al.   EUROPEAN JOURNAL OF HEART FAILURE

Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population

(2008) Luis Alberto García Rodríguez et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial

(2008) John A Baron et al.   LANCET

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

(2008) Emil Loldrup Fosbøl et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY